Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Amundi    AMUN   FR0004125920

AMUNDI (AMUN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweetsMarketScreener Strategies

Amundi : Close to a key level on the weekly chart

share with twitter share with LinkedIn share with facebook
share via e-mail
11/08/2018 | 01:12pm CET
long trade
Stop-loss triggered
Entry price : 53.14€ | Target : 58€ | Stop-loss : 50.7€ | Potential : 9.15%
The decline over the past weeks has brought the price of Amundi shares back to an important technical support level at 51.7 EUR. This represents an opportunity to take advantage of these prices levels.
Investors have an opportunity to buy the stock and target the € 58.
Chart AMUNDI
Duration : Period :
Amundi Technical Analysis Chart | MarketScreener
Full-screen chart
Strengths
  • The share is getting closer to its long-term support in weekly data, at EUR 51.7, which offers good timing for buyers.
  • Graphically speaking, the timing seems perfect for purchasing the stock close to the EUR 51.52 support.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The group usually releases upbeat results with huge surprise rates.
  • The company is one of the best yield companies with high dividend expectations.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses
  • With an enterprise value anticipated at 4.25 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The underlying tendency is negative on the weekly chart below the resistance at 62 EUR

Anaïs Lozach
© Zonebourse.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (€)
Sales 2018 2 626 M
EBIT 2018 1 275 M
Net income 2018 885 M
Debt 2018 601 M
Yield 2018 6,16%
P/E ratio 2018 10,82
P/E ratio 2019 10,09
EV / Sales 2018 3,91x
EV / Sales 2019 3,89x
Capitalization 9 678 M
Upcoming event on AMUNDI
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 71,0 €
Spread / Average Target 48%
EPS Revisions
Managers
NameTitle
Yves Perrier Chief Executive Officer & Director
Xavier Musca Chairman
Guillaume Lesage Head-Operations, Services & Technology Division
Nicolas Calcoen Chief Financial Officer & Director-Strategy
François Véverka Director
Sector and Competitors
1st jan.Capitalization (M$)
AMUNDI-32.09%11 050
T. ROWE PRICE GROUP-8.63%23 072
LEGAL & GENERAL-10.79%18 642
HARGREAVES LANSDOWN2.66%11 257
STANDARD LIFE ABERDEEN PLC-40.61%8 493
EATON VANCE CORP-24.40%5 050